| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. | Chief Legal Officer | Stock Option (Right to Buy) | 38,489 | $1,839,774 | $47.80 | 10 Feb 2022 | Direct |
| Zentalis Pharmaceuticals, Inc. | Chief Legal Officer | Common Stock | 22,240 | $228,841 | $10.29 | 14 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ZNTL | Zentalis Pharmaceuticals, Inc. | 10 Feb 2022 | 4 | -$34,708 | 4 | Chief Legal Officer | 14 Feb 2022, 20:10 |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 25 Oct 2021 | 6 | -$1,300,002 | 4 | Chief Legal Officer | 27 Oct 2021, 20:13 |